WO2025162173 - USE IN TREATMENT OF BREAST CANCER TREATED WITH CDK4/6 INHIBITORS
National phase entry is expected:
Publication Number
WO/2025/162173
Publication Date
07.08.2025
International Application No.
PCT/CN2025/074229
International Filing Date
23.01.2025
Title **
[English]
USE IN TREATMENT OF BREAST CANCER TREATED WITH CDK4/6 INHIBITORS
[French]
UTILISATION DANS LE TRAITEMENT DU CANCER DU SEIN TRAITÉ AVEC DES INHIBITEURS DE CDK4/6
[Chinese]
治疗经CDK4/6抑制剂治疗后的乳腺癌用途
Applicants **
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
Inventors
TIAN, Xin
FENG, Fan
YU, Ding
WANG, Jinan
ZHANG, Ying
WANG, Xunqiang
ZHANG, Xiquan
SHI, Wei
XU, Hongjiang
HE, Lihua
Priority Data
202410171492.4
04.02.2024
CN
202411606032.6
11.11.2024
CN
202510097524.5
21.01.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1830 | |
| EPO | Filing, Examination, Granting | 11558 | |
| Japan | Filing, Examination, Granting | 2153 | |
| South Korea | Filing, Examination, Granting | 2203 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
24,884
Contact Us
Abstract[English]
A compound of formula (I) for treatment of breast cancer resistant to CDK4/6 inhibitors or a pharmaceutically acceptable salt thereof and a use thereof in treatment of breast cancer resistant to CDK4/6 inhibitors.[French]
L'invention concerne un composé de formule (I) pour le traitement du cancer du sein résistant aux inhibiteurs de CDK4/6 ou un sel pharmaceutiquement acceptable de celui-ci et son utilisation dans le traitement du cancer du sein résistant aux inhibiteurs de CDK4/6.[Chinese]
一种用于治疗CDK4/6抑制剂耐药的乳腺癌的式(I)化合物或其药学上可接受的盐及其治疗CDK4/6抑制剂耐药的乳腺癌的用途。